All In Biotech

Drug Trial Radar · NCT04970836

The Immune Responses After Hepatitis B Revaccination Doses in a Young Cohort

Last checked: Nov 20, 2026Latest source record: Oct 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

240

Planned (sponsor's estimate)

Start

Aug 1, 2021

Primary completion

Dec 31, 2027

Study completion Dec 31, 2027

Sponsor

Lead sponsor
National Taiwan University HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Academia Sinica, Taiwan; Ministry of Science and Technology, Taiwan
First posted
Jul 21, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 20 years, up to 36 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This prospective cohort study aims to provide the evidence-based clinical guide to help decide the revaccination doses of hepatitis B vaccine that the high-risk young adults without hepatitis B seroprotective antibodies (anti-HBs titer\<10 mIU/mL) need to take.

Conditions

  • Hepatitis B
  • Vaccination; Infection
  • Preventable Disease, Vaccine

Interventions

  • recombinant hepatitis B vaccineBiological

    Hepatitis B vaccine (Engerix-B) will be administered to the eligible participants by 4 groups. Each case will be tracked for 12 months, at 0, 7-10 days, 28 days, 24-28 weeks, 48-52 weeks anti-HBs titer concentration and 4 follow-up questionnaires.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. anti-HBs titer response rate at 7-10 daysTime frame: 7-10 days
  2. anti-HBs titer response rate at one monthTime frame: 28 days
  3. anti-HBs titer response rate at 6 monthsTime frame: 24-28 weeks
  4. anti-HBs titer response rate at 12 monthsTime frame: 48-52 weeks
  5. anti-HBs titer immune response change at 12 monthsTime frame: 48-52 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Family Medicine, NTUH

    Taipei, Taipei, Taiwan · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.